Lee Jacks 4

What Happened

• Lee Jacks, a director of Vaxcyte, received equity awards on June 15, 2026: 2,265 shares granted (no cash paid) and 11,389 derivative awards recorded at $0.00. These are grants/awards (not open-market purchases or sales).

Key Details

• Transaction date: June 15, 2026; Form 4 filed June 16, 2026 (timely filing).
• Grants: 2,265 shares acquired @ $0.00; 11,389 derivative units acquired @ $0.00.
• Shares owned after the transaction: not specified in the provided excerpt of the filing.
• Footnotes: F1 describes RSUs (each RSU = right to receive one share) that vest on the earlier of June 15, 2027 or the day before the next annual meeting, subject to acceleration and continuous service. F2 indicates certain shares subject to an option that vest monthly and fully vest on the same schedule.
• No sale or cash exercise reported; these are compensation awards.

Context

• These awards are compensation-related grants rather than purchases — RSUs are contingent rights to receive shares upon vesting, and options (if applicable) vest monthly before they can be exercised. Such grants are common for directors and do not by themselves indicate intent to buy or sell stock in the market.